SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-05-011511
Filing Date
2005-03-16
Accepted
2005-03-16 16:37:25
Documents
7
Period of Report
2005-03-15
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a05-5179_18k.htm 8-K 38586
2 EX-99.1 a05-5179_1ex99d1.htm EX-99.1 8927
3 EX-99.2 a05-5179_1ex99d2.htm EX-99.2 15569
4 EX-99.3 a05-5179_1ex99d3.htm EX-99.3 104251
5 GRAPHIC g51791mmimage002.gif GRAPHIC 4311
6 GRAPHIC g51791moimage002.gif GRAPHIC 4311
7 GRAPHIC g51791mqimage010.gif GRAPHIC 5631
  Complete submission text file 0001104659-05-011511.txt   183994
Mailing Address 22026 20TH AVENUE SE, SUITE 102 BOTHELL WA 98021
Business Address 22026 2OTH AVE SE STE 102 BOTHELL WA 98021 2064879500
SONUS PHARMACEUTICALS INC (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21243 | Film No.: 05685953
SIC: 2835 In Vitro & In Vivo Diagnostic Substances